Vitiligo
1988; Wiley; Volume: 27; Issue: 10 Linguagem: Dinamarquês
10.1111/j.1365-4362.1988.tb01260.x
ISSN1365-4632
AutoresR V Koranne, D. Derm., Karan Sachdeva,
Tópico(s)Mast cells and histamine
ResumoInternational Journal of DermatologyVolume 27, Issue 10 p. 676-681 Vitiligo R. V. Koranne M.D., Corresponding Author R. V. Koranne M.D. From the Department of Dermotology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant and Safdarjung Hospitals, New Delhi, IndiaAddress for correspondence: Dr. R.V. Koranne, Z-48 Sarojini Nagar, New Delhi-110023, India.Search for more papers by this authorD. Derm., D. Derm. From the Department of Dermotology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant and Safdarjung Hospitals, New Delhi, IndiaSearch for more papers by this authorK. G. Sachdeva M.D., K. G. Sachdeva M.D. From the Department of Dermotology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant and Safdarjung Hospitals, New Delhi, IndiaSearch for more papers by this author R. V. Koranne M.D., Corresponding Author R. V. Koranne M.D. From the Department of Dermotology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant and Safdarjung Hospitals, New Delhi, IndiaAddress for correspondence: Dr. R.V. Koranne, Z-48 Sarojini Nagar, New Delhi-110023, India.Search for more papers by this authorD. Derm., D. Derm. From the Department of Dermotology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant and Safdarjung Hospitals, New Delhi, IndiaSearch for more papers by this authorK. G. Sachdeva M.D., K. G. Sachdeva M.D. From the Department of Dermotology and Venereology, Maulana Azad Medical College and Associated LNJPN and GB Pant and Safdarjung Hospitals, New Delhi, IndiaSearch for more papers by this author First published: December 1988 https://doi.org/10.1111/j.1365-4362.1988.tb01260.xCitations: 44AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and Other Hypomelanosis of Hair and Skin. New York : Plenum Medical Book Company, 1983: 129– 310. 2 Pinkus H. Vitiligo—what is it J Invest Dermatol. 1959; 32: 281– 284. 3 Lerner AB. Vitiligo. J Invest Dermatol. 1959; 32: 285– 310. 4 Nair BKH. Vitiligo—A retrospect. Int J Dermatol. 1978; 17: 755– 757. 5 Bateman T. A practical synopsis of cutaneous disease 1813;Johnson J London (Quoted by Nair 1978). 6 Fitzpatrick TB. Hypomelanosis. South Med J. 1964; 57: 995. 7 Leider M, Rosenblum M. A dictionary of Dermatological Words, Terms and Phrases. New York : McGraw-Hill, 1968. 8 Whitney WD. Atharva Veda Samhita (Translation and notes). Harvard Oriental Series, Vol. 7. Cambridge, MA: Harvard University Press, 1905. (quoted by Fitzpatrick and Pathak, 1959). 9 El-Mofty AM. Vitiligo and Psoralens. London : Pergamon Press, 1968: 1– 12. 10 Biblical times (Special article). Arch Dermatol. 1966; 93: 744– 753. 11 Mosher DB, Fitzpatrick TB, Ortonne JP, et al. Abnormalities of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. Dermatology in General Medicine, 3rd ed. New York : McGraw-Hill, 1986: 794– 876. 12 Lobitz WC Jr. The HLA System in dermatology. In: Rook A, Savin J. Recent Advances in Dermatology, 5th ed. Edinburgh : Churchill Livingstone, 1980: 51– 52. 13 Mohr J. Vitiligo in a pair of mono-ovular twins. Acta Genet. 1951; 2: 252– 255. 14 Leading article (Editorial): Aetiology of vitiligo. Lancet. 1971; 2: 1298– 1299. 15 Cunliffe WJ, Newell DJ, Stevenson CJ. Vitiligo, thyroid diseases and autoimmunity. Br J Dermatol. 1968; 80: 135– 139. 16 Betterle C, Peserico A, Bersani G. Vitiligo and autoimmune polyendocrine deficiencies with autoantibodies to melanin producing cells. Arch Dermatol 1979; 115: 364– 371. 17 Harsoulis P, Kanakoudi-Tsakalidis F, Vynantiadis A, et al. Auto-immunity and vitiligo. Arch Dermatol. 1972; 114: 1554. 18 Lerner AB. On the aetiology of vitiligo and gray hair. Am J Med. 1971; 51: 141– 147. 19 Brown WH. The aetiology of alopecia areata and its relationship to vitiligo and possibly scleroderma. Br J Dermatol. 1929; 41: 299– 323. 20 Sehgal VN. A clinical evaluation of 202 cases of vitiligo. Cutis. 1974; 14: 440– 445. 21 Sehgal VN, Rege VL, Desia SC. Vitiligo and myasthenia gravis. Ind J Dermatol Venereol Leprol. 1976; 42: 1– 2. 22 Koranne RV, Sehgal VN, Sachdeva KG. An association of vitiligo with pemphigus vulgaris. Ind J Dermatol Venereol Leprol. 1986; 52: 107– 108. 23 Copeman PWA, Lewis MG, Bleehen SS. Biology and immunology of vitiligo and cutaneous malignant melanoma. In: Recent Advances in Dermatology, 3rd ed. Edinburgh : Churchill Livingstone, 1973: 252– 284. 24 Brostoff J, Bor S, Feiwel M. Autoantibodies in patients with vitiligo. Lancet. 1969; 2: 177– 178. 25 Dunlop D. Eighty six cases of Addison's disease. Br Med J. 1963; 2: 887– 890. 26 McGregor BC, Katz HI, Doe RP. Vitiligo and multiple glandular deficiencies. JAMA. 1972; 219: 724– 725. 27 Bor S, Feiwell M, Chaharin I. Vitiligo and its aetiological relationship to organ-specific auto-immune diseases. Br J Dermatol. 1929; 41: 299– 323. 28 Howantz F, Nordulund JL, Lerner AB, et al. Antibodies to melanocytes (occurrence in patient with vitiligo and chronic muco-cutaneous candidiasis). Arch Dermatol. 1981; 117: 705– 708. 29 Peserico A, Rigori F, Semenzato G, et al. Vitiligo and polyglandular autoimmune diseases with autoantibodies to melanin producing cells—a new syndrome. Arch Dermatol. 1981; 117: 751– 752. 30 Naughton GK, Eisinger M, Bystrum JC. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol. 1983; 81: 540. 31 Chanco-Turner ML, Lerner AB. Physiological changes in vitiligo. Arch Dermatol. 1965; 91: 390– 396. 32 Morohashi M, Hashimota K, Goodman TF, et al. Ultrastructural studies of vitiligo, Vogt-Koyangi syndrome and incontinentia pigmenti achromicans. Arch Dermatol. 1977; 113: 755– 766. 33 Powlek J, Korner A, Bergstrom A, et al. New regulators of melanin biosynthesis and auto-destruction of melanoma cells. Nature. 1980; 286: 617– 619. 34 Burn R. A propos de I' etiologie du vitiligo. Dermatologica. 1972; 145: 169– 174. 35 Riley RA. Mechanism of pigment cell toxicity produced by hydroxyanisole. J Pathol. 1970; 101: 163– 169. 36 Denton CR, Lerner AB, Fitzpatrick TB. Inhibition of melanin formation by chemical agents. J Invest Dermatol. 1952; 18: 119– 135. 37 Bleehan SS, Pathak MA, Hori Y, et al. Depigmentation of skin with 4-lsopropylcatechole, Mercaptomines and other compounds. J Invest Dermatol (Suppl). 1968; 50: 103– 112. 38 Levia M. A study of certain contributory factors. Arch Dermatol Syphilol. 1958; 78: 364– 369. 39 Banerjee BN, Pal SK. Leucoderma. Ind J Dermatol. 1956; 2: 1– 10. 40 Lahiri KD. Leucoderma. Ind J Dermatol. 1959; 4: 78– 86. 41 Behl PN, Bhatia RK. 400 cases of vitiligo—a clinico-therapeutic analysis. Ind J Dermatol. 1971; 17: 51– 54. 42 Dutta AK, Mandal SB. A clinical study of 650 cases of vitiligo. Ind J Dermatol. 1969; 14: 103– 111. 43 Hajini CH, Hussain ST, Sofi CM, et al. Vitiligo and glucose tolerance test. Ind J Dermatol Venereol Leprol. 1977; 43: 143– 144. 44 Sarin RC, Kumar AJ. A clinical study of vitiligo. Ind J Dermatol Venereol Leprol. 1977; 43: 311– 314. 45 Grunnet I, Howitz J, Raymann F, et al. Vitiligo and Pernicious anaemia. Arch Dermatol. 1970; 101: 82– 85. 46 Forsham P. Adrenal insufficiency. In: Textbook of Endocrinology. Philadelphia : WB Saunders, 1968: 324. 47 Dawber RPR. Vitiligo in maturity-onset diabetes mellitus. Br J Dermatol. 1968; 80: 275– 278. 48 Lever WF, Lever-Schaumberg G. Vitiligo. In: Lever WF, Lever-Schaumberg G. Histopathology of the Skin, Philadelphia : JB Lippincott, 1986: 441– 442. 49 Zelickson AS, Mottaz JH. Epidermal dendritic cells. Arch Dermatol. 1968; 98: 652– 659. 50 Riley RA. A study of the distribution of epidermal dendritic cells in pigmented and unpigmented skin. J Invest Dermatol. 1967; 48: 28– 38. 51 Birbeck MS, Breathnach AS, Everall JD. An electron microscopy study of basal melanocytes and high level clear cells (Lan-gerhans cells) in vitiligo. J Invest Dermatol. 1961; 37: 51– 64. 52 Brown J, Winkelman RK, Wolfe K. Langerhans cells in vitiligo. J Invest Dermatol. 1967; 49: 386– 390. 53 Mishima Y, Kawasaki H, Pinkus H. Dendritic cell dynamics in progressive depigmentation. Arch Dermatol Forsch. 1972; 243: 67– 87. 54 Bloch P. Dopa reaction of bloch. Z Physiol Chem. 1917; 98: 228. 55 Laidlaw, Blackberg. Dopa reaction. Am J Pathol. 1932; 8: 491. 56 Jarret A, Szabo G. The pathological varieties of vitiligo and their response to treatment with meladinine. Br J Dermatol. 1956; 68: 313– 326. 57 Ito K. Ultra-structural observations of dendritic cells in the repigmented areas of vitiligo: electron microscopic studies on dopa-oxidase in melanocytes which are present between the epidermal basal cells in the repigmented areas of vitiligo. Jpn J Dermatol. 1975; 85: 33. Citing Literature Volume27, Issue10December 1988Pages 676-681 ReferencesRelatedInformation
Referência(s)